2022年10月3日,

斯賓塞·赫爾斯(Spencer Hulse)已得到Muck Rack編輯團隊的驗證2022年10月3日發布。最近，美國藥品管製局(DEA)打擊了開管控藥物處方的精神健康遠程醫療公司。最近，專注於多動症在線治療的遠程醫療初創公司Done就見證了這一點。然而，甚至在此之前，另一家名為大腦的初創公司發現自己受到了調查，這導致了公司的重大變化。目前，在一名17歲的患者未經父母同意接受治療而死亡後，大腦醫院正麵臨著公眾的監督。遠程醫療公司的崛起是在大流行期間出現的，當時人們迫切需要醫療服務，但卻對去醫生辦公室和醫院心存警惕。在此期間，DEA放寬了對受管製藥物的處方要求，因此他們不必親自開處方。隨之而來的是在線處方和治療的革命。但也不全是好消息。雖然在網上開處方很方便，有助於促進獲得醫療服務，但也存在一些問題，比如有指控稱，“大腦”治療未成年人，並在未經父母同意的情況下開處方。《華爾街日報》曾對這一情況進行過報道，詳細介紹了一名17歲的病人安東尼·克羅爾(Anthony Kroll)的治療案例，後者後來自殺了。 It mentioned that while the startup uses software to verify customer IDs, it did not check birth dates or other details. Because of the policy, there have been a few cases of minors being treated without parental consent, with Cerebral eventually identifying 17 minors enrolled in their services from May 2021 to April 2022. According to Cerebral, the case is an outlier, and it has followed state rules every step of the way. The company also pointed out that it has “provided much-needed care to hundreds of thousands of patients, many of whom would not have had access to critical mental-health support without Cerebral’s telemental health services.” The Wall Street Journal mentioned a company memo that referred to the software ID check as an “impediment to customer retention.” The company was quickly enrolling tens of thousands of customers during the pandemic, so it chose to use software to capture selfies and had clinicians verify details during 30-minute video chats. When Anthony Kroll went through the sign-up process, his ID went through the software. He then proceeded to his video chat with a clinician, who he informed of suicidal thoughts. The clinician then prescribed antidepressants, which carried a warning label for adolescents. Anthony later committed suicide. The medication is not certain to have caused the tragic death, but it is an unnecessary potential factor due to his status as an adolescent. Additionally, because they were not informed, Anthony’s parents were unaware that he was seeking treatment or taking the prescribed medication. But the allegations concerning the startup prescribing to minors are not the first trouble it has faced. Cerebral was also under investigation in the past for its prescribing practices, which eventually led to the company announcing that it would stop prescribing drugs in the stimulant category. There have also been instances where people expressed their concerns over Cerebral’s quick sessions and the qualifications of its prescribers . In some instances, prescriptions were handed out in as quickly as 15 minutes, and there were cases where patients were prescribed five or more medications. Moreover, many of Cerebral’s prescribers are nurse practitioners and not board-certified psychologists. Tags